欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > PI3K/Akt/mTORsignaling > XL-147

浏览历史

S81118

XL-147

源叶(MedMol) 98%
  • 英文名:
  • XL-147
  • 别名:
  • CAS号:
  • 934526-89-3
  • 分子式:
  • C25H25ClN6O4S
  • 分子量:
  • 541.02
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S81118-2mg 98% ¥297.50元 9 - - - EA 加入购物车
源叶(MedMol) S81118-5mg 98% ¥501.50元 7 - - - EA 加入购物车
源叶(MedMol) S81118-10mg 98% ¥977.50元 7 - - - EA 加入购物车
源叶(MedMol) S81118-25mg 98% ¥1615.00元 5 - - - EA 加入购物车
源叶(MedMol) S81118-50mg 98% ¥2450.00元 预计交期:2-3天 - - - EA 加入购物车
源叶(MedMol) S81118-100mg 98% ¥3900.00元 预计交期:2-3天 - - - EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Pilaralisib (XL147; SAR245408) is a potent and highly selective class I PI3Ks inhibitor with IC50s of 39 nM, 383 nM, 23 nM and 36 nM for PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ.
  • 靶点: PI3Kα:39 nM (IC50);PI3Kβ:383 nM (IC50);PI3Kδ:36 nM (IC50);PI3Kγ:23 nM (IC50);Vps34:6974 nM (IC50);DNA-PK:4750 nM (IC50);PI3K
  • 体内研究:
    The ability of Pilaralisib (XL147) to inhibit this endogenous phosphorylation of AKT, p70S6K, and S6 is examined following a single oral dose of 10, 30, 100, or 300 mg/kg. The tumors are harvested 4, 24, or 48 hours postdose and homogenized in lysis buffer. Tumor lysates from each animal (n=4) are then pooled for each group and analyzed for levels of total and phosphorylated AKT, p70S6K, and S6 by Western immunoblotting. Administration of Pilaralisib (XL147) causes a dose-dependent decrease in phosphorylation of AKT, p70S6K, and S6 in the tumors, reaching a maximum of 81% inhibition of AKT phosphorylation at 300 mg/kg at 4 hours. The dose-response relationships derived from the 4-hour time point predict 50% inhibition of AKT, p70S6K, and S6 phosphorylation at doses of approximately 100 mg/kg (pAKTT308), 54 mg/kg (pAKTS473), 71 mg/kg (p-p70S6K), and 103 mg/kg (pS6). The inhibition of AKT, p70S6K, and S6 phosphorylation in MCF7 tumors following a 100 mg/kg dose of Pilaralisib (XL147) is maximal at 4 hours, reaching 55% to 75%; however, the level of inhibition decreased to 8% to 45% by 24 hours, and only minimal or no inhibition was evident by 48 hours. Following a 300 mg/kg dose of Pilaralisib (XL147), inhibition is also maximal at 4 hours (65%-81%). However, in contrast with the 100 mg/kg dose, inhibition at 24 hours (51%-78%) is almost comparable with that seen at 4 hours, and partial inhibition (25%-51%) persisted through 48 hours
  • 参考文献:
    1. Foster P, et al. The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models. Mol Cancer Ther. 2015 Apr;14(4):931-40.
  • 溶解性: DMSO  :  ≥  100  mg/mL  (184.84  mM)
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.848 ml 9.242 ml 18.484 ml
    5 mM 0.37 ml 1.848 ml 3.697 ml
    10 mM 0.185 ml 0.924 ml 1.848 ml
    50 mM 0.037 ml 0.185 ml 0.37 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。